🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11581+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11581 recruiting trials

Phase 2, PHASE3RecruitingNCT06647498

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

👨‍⚕️ Eric M McDade, DO, Washington University School of Medicine📍 35 sites📅 Started Nov 2024View details ↗
Phase 2, PHASE3RecruitingNCT05552157

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

👨‍⚕️ Eric M McDade, DO, Washington University School of Medicine📍 35 sites📅 Started Nov 2024View details ↗
EARLY_Phase 1RecruitingNCT06747260

Feasibility and Safety of Intranasally Administered Breast Milk in HIE

👨‍⚕️ Unoke Meder, MD, PhD, Department of Neonatology, Pediatric Center, Semmelweis University, Budapest, Hungary📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06617325

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

👨‍⚕️ UCB Cares, 001 844 599 2273 (UCB)📍 225 sites📅 Started Nov 2024View details ↗
RecruitingNCT06820008

Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project

👨‍⚕️ Dara Meldrum, PhD, University of Dublin, Trinity College📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06619561

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

👨‍⚕️ Clinical Team, Deciphera Pharmaceuticals, LLC📍 26 sites📅 Started Nov 2024View details ↗
Phase 1RecruitingNCT06671236

Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases

🏥 Novabio Therapeutics📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT07261891

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

👨‍⚕️ Rik Schrijvers, MD, PhD, UZ Leuven📍 1 site📅 Started Nov 2024View details ↗
Phase 1RecruitingNCT06567769

Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)

🏥 GC Biopharma Corp📍 5 sites📅 Started Nov 2024View details ↗
NARecruitingNCT06734637

Efficacy and Safety of Peginterferon in ET and PV.

👨‍⚕️ ZhenYa Hong, Ph.D, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06510894

Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression

👨‍⚕️ Paco Bravo, MD, University of Pennsylvania📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06686927

Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06813508

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

👨‍⚕️ Fabio Piscaglia, Prof, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06888063

Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery

👨‍⚕️ Bas Groot Koerkamp, MD, PhD, Erasmus Medical Center📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT07254754

Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma

👨‍⚕️ Mariana Bastos-Oreiro, Hospital General Universitario Gregorio Marañón📍 15 sites📅 Started Nov 2024View details ↗
RecruitingNCT07448727

Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT

🏥 University of Rome Tor Vergata📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06683846

Ivonescimab in the Treatment of Multiple Advanced Tumors

👨‍⚕️ Hongxia Wang, Doctor, Fudan University📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06700304

CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

🏥 Neuralink Corp📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06790875

Effects of Low Tidal Volume and Airway Pressure Release Ventilation on Lung Tissue Mechanics in ARDS Patients Under Mechanical Ventilation: A Prospective Randomized Crossover Study

🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06682169

Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

🏥 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.📍 41 sites📅 Started Nov 2024View details ↗
← PreviousPage 202 of 580Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →